Pratt Daniel, Kirkpatrick Tim, Awenat Yvonne, Hendricks Caroline, Perry Amanda, Carter Leslie-Anne, Crook Rebecca, Duxbury Paula, Lennox Charlotte, Knowles Sarah, Brooks Helen, Davies Linda, Shields Gemma, Honeywell David, Appleby Louis, Gooding Patricia, Edge Dawn, Emsley Richard, Shaw Jenny, Haddock Gillian
School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Manchester Academic Health Science Centre, Manchester, UK.
BMC Psychiatry. 2024 Dec 18;24(1):927. doi: 10.1186/s12888-024-06320-y.
Suicide is the leading cause of preventable death in prisons. Deaths from suicide in prison are significantly, and persistently, elevated compared to those living in the community. Psychological therapies have been shown to be a potentially effective means of alleviating suicidal thoughts, plans and behaviours, but patients located in prison often have no access to evidence-based psychological interventions targeting suicide. The objectives of this programme of research are to investigate the clinical and cost effectiveness of a new psychological therapy programme delivered to male prisoners at risk of suicide.
The PROSPECT trial is a two-armed single blind, pragmatic, randomised controlled trial and will recruit a target sample size of 360 male prisoners, identified as at-risk of suicide, across 4 prisons in the North of England. Participants will be randomised to receive a psychological talking therapy (Cognitive Behavioural Suicide Prevention, CBSP) plus treatment as usual, or treatment as usual alone. Co-primary outcomes (Suicide Ideation and Suicide Behaviours), as well as related secondary outcomes, will be assessed at baseline and at 6-months follow-up. An intention to treat analysis will be conducted with primary stratification based on prison site and lifetime history of suicide attempt (yes/no). A nested qualitative process evaluation will investigate the nature and context in which the intervention is delivered, with specific focus upon the facilitators and barriers to the implementation of the therapy within prisons.
The key outputs from this trial will be to determine whether a psychological therapy for suicidal prisoners is clinically and cost effective; and to generate a project implementation platform that identifies how best to implement the new intervention across the broader prison estate.
ISRCTN (reference ISRCTN14056534 https://www.isrctn.com/ISRCTN14056534 ; 24th September 2021). Registration confirmed prior to participant recruitment commencing. Modifications to protocol are listed on the study website at ISRCTN.
自杀是监狱中可预防死亡的首要原因。与社区居民相比,监狱中的自杀死亡人数显著且持续居高不下。心理治疗已被证明是缓解自杀念头、计划和行为的一种潜在有效手段,但监狱中的患者往往无法获得针对自杀的循证心理干预措施。本研究项目的目标是调查为有自杀风险的男性囚犯提供的一种新的心理治疗方案的临床效果和成本效益。
“展望”试验是一项双臂单盲、务实的随机对照试验,将在英格兰北部的4所监狱招募360名被确定有自杀风险的男性囚犯作为目标样本。参与者将被随机分配接受一种心理谈话治疗(认知行为自杀预防,CBSP)加常规治疗,或仅接受常规治疗。将在基线和6个月随访时评估共同主要结局(自杀意念和自杀行为)以及相关次要结局。将基于监狱地点和自杀未遂的终身史(是/否)进行主要分层,开展意向性分析。一项嵌套的定性过程评估将调查干预措施实施的性质和背景,特别关注监狱内实施该治疗的促进因素和障碍。
该试验的主要成果将是确定针对有自杀倾向囚犯的心理治疗在临床和成本效益方面是否有效;并生成一个项目实施平台,确定如何在更广泛的监狱系统中最佳地实施这种新干预措施。
ISRCTN(注册号ISRCTN14056534,https://www.isrctn.com/ISRCTN14056534;2021年9月24日)。在开始招募参与者之前已确认注册。方案修改情况列于ISRCTN的研究网站上。